We may hypothesize that the biomarker profiles observed reflected a more “advanced” stage of the disease, with more pathophysiological changes, such as atrial stretch and dilatation (associated with NT-proBNP release), taking place in patients with established AF, in comparison to patients with paroxysmal AF. The gene discussed is NPPB; the disease is atrial fibrillation.